Cardiovascular outcomes and LDL-cholesterol levels in EMPA-REG OUTCOME(®)

OBJECTIVE: It is well established that higher low-density lipoprotein (LDL)-cholesterol levels are associated with increased cardiovascular risk. We analyzed whether effects of empagliflozin on cardiovascular outcomes varied by different LDL-cholesterol levels at baseline in EMPA-REG OUTCOME. METHOD...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Diab Vasc Dis Res
Prif Awduron: Langslet, Gisle, Zinman, Bernard, Wanner, Christoph, Hantel, Stefan, Espadero, Rosa-Maria, Fitchett, David, Johansen, Odd Erik
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: SAGE Publications 2020
Pynciau:
Brief Report
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7919220/
https://ncbi.nlm.nih.gov/pubmed/33307785
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1479164120975256
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg